ArticleJournal for immunotherapy of cancer2022

Intratumoral administration of STING-activating nanovaccine enhances T cell immunotherapy.

Xiaoyi Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.